Overview

Improving Fibrosis Outcomes With Metformin

Status:
Withdrawn

Trial end date:
2018-04-03

Target enrollment:

Participant gender:

Summary

This study will evaluate the role of Metformin on liver fibrosis in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance receiving DAA HCV treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Ottawa Hospital Research Institute

Collaborator:

CIHR Canadian HIV Trials Network

Treatments:

Metformin